Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in AYTU — Aytu Biopharma, Inc

CIK 1000275 TORONTO, A6
Back to AYTU Full portfolio

Position in AYTU

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$812
+$714 QoQ
Shares Held
378
+950.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 38 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AYTU Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. AYTU ranks #58 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
 9,213,269 $133,500,266
2 ZTS
Zoetis Inc.
 1,828,326 $131,383,499
3 NBIX
Neurocrine Biosciences Inc
 583,476 $98,339,041
4 BHC
Bausch Health Companies Inc.
 10,832,582 $53,404,627
5 VTRS
Viatris Inc
 3,135,460 $49,791,098
6 UTHR
UNITED THERAPEUTICS Corp
 62,600 $33,918,552
7 TEVA
Teva Pharmaceutical Industries Ltd
 953,413 $32,301,629
8 HLN
Haleon plc
 3,385,489 $31,586,609

All Filings in AYTU

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $812 378
2026-03-31 $98 36
2025-12-31 $65 25
2024-06-30 $9,592 3,285
2024-03-31 $8,235 2,709
2023-12-31 $10,220 3,599
2023-09-30 $406 151
2023-06-30 $434 272
2023-03-31 $51 23
2022-12-31 $96 511
2022-09-30 $90 479
2022-06-30 $328 476
2022-03-31 $514 476
2021-12-31 $685 508
2021-09-30 $1,681 584
2021-06-30 $28,877 5,764
2021-03-31 $15,124 1,990
2020-12-31 $1,033 173
2020-09-30 $1 1
2020-03-31 $519 346